| Metastasis is regulated via microRNA-200/ZEB1 axis control of tumour cell PD-L1 expression and intratumoral immunosuppression L Chen, DL Gibbons, S Goswami, MA Cortez, YH Ahn, LA Byers, X Zhang, ... Nature communications 5 (1), 5241, 2014 | 978 | 2014 |
| Antielastin autoimmunity in tobacco smoking–induced emphysema SH Lee, S Goswami, A Grudo, L Song, V Bandi, S Goodnight-White, ... Nature medicine 13 (5), 567-569, 2007 | 805 | 2007 |
| The next decade of immune checkpoint therapy P Sharma, BA Siddiqui, S Anandhan, SS Yadav, SK Subudhi, J Gao, ... Cancer discovery 11 (4), 838-857, 2021 | 550 | 2021 |
| Immune checkpoint therapy—current perspectives and future directions P Sharma, S Goswami, D Raychaudhuri, BA Siddiqui, P Singh, ... Cell 186 (8), 1652-1669, 2023 | 417 | 2023 |
| Immune profiling of human tumors identifies CD73 as a combinatorial target in glioblastoma S Goswami, T Walle, AE Cornish, S Basu, S Anandhan, I Fernandez, ... Nature medicine 26 (1), 39-46, 2020 | 309 | 2020 |
| Neoadjuvant PD-L1 plus CTLA-4 blockade in patients with cisplatin-ineligible operable high-risk urothelial carcinoma J Gao, N Navai, O Alhalabi, A Siefker-Radtke, MT Campbell, RS Tidwell, ... Nature medicine 26 (12), 1845-1851, 2020 | 269 | 2020 |
| Modulation of EZH2 expression in T cells improves efficacy of anti–CTLA-4 therapy S Goswami, I Apostolou, J Zhang, J Skepner, S Anandhan, X Zhang, ... The Journal of clinical investigation 128 (9), 3813-3818, 2018 | 209 | 2018 |
| CXCR2 expression in tumor cells is a poor prognostic factor and promotes invasion and metastasis in lung adenocarcinoma P Saintigny, E Massarelli, S Lin, YH Ahn, Y Chen, S Goswami, B Erez, ... Cancer research 73 (2), 571-582, 2013 | 188 | 2013 |
| Myeloid cell-targeted therapies for solid tumours S Goswami, S Anandhan, D Raychaudhuri, P Sharma Nature Reviews Immunology 23 (2), 106-120, 2023 | 134 | 2023 |
| Divergent functions for airway epithelial matrix metalloproteinase 7 and retinoic acid in experimental asthma S Goswami, P Angkasekwinai, M Shan, KJ Greenlee, WT Barranco, ... Nature immunology 10 (5), 496-503, 2009 | 125 | 2009 |
| ARID1A mutation plus CXCL13 expression act as combinatorial biomarkers to predict responses to immune checkpoint therapy in mUCC S Goswami, Y Chen, S Anandhan, PM Szabo, S Basu, JM Blando, W Liu, ... Science translational medicine 12 (548), eabc4220, 2020 | 103 | 2020 |
| Immune checkpoint therapies in prostate cancer S Goswami, A Aparicio, SK Subudhi The Cancer Journal 22 (2), 117-120, 2016 | 66 | 2016 |
| Suggestive evidence of association of C-159T functional polymorphism of the CD14 gene with atopic asthma in northern and northwestern Indian populations M Sharma, J Batra, U Mabalirajan, S Goswami, D Ganguly, B Lahkar, ... Immunogenetics 56, 544-547, 2004 | 60 | 2004 |
| The next decade of immune checkpoint therapy. Cancer Discov. 2021; 11: 838–857. doi: 10.1158/2159-8290 P Sharma, BA Siddiqui, S Anandhan, SS Yadav, SK Subudhi, J Gao, ... CD-20-1680, 2020 | 59 | 2020 |
| Frontiers in cancer immunotherapy—a symposium report J Cable, B Greenbaum, D Pe'er, CM Bollard, S Bruni, ME Griffin, ... Annals of the New York Academy of Sciences 1489 (1), 30-47, 2021 | 56 | 2021 |
| A phase 1-2 trial of sitravatinib and nivolumab in clear cell renal cell carcinoma following progression on antiangiogenic therapy P Msaouel, S Goswami, PF Thall, X Wang, Y Yuan, E Jonasch, J Gao, ... Science translational medicine 14 (641), eabm6420, 2022 | 49 | 2022 |
| Identification of P311 as a potential gene regulating alveolar generation L Zhao, JK Leung, H Yamamoto, S Goswami, F Kheradmand, TH Vu American journal of respiratory cell and molecular biology 35 (1), 48-54, 2006 | 49 | 2006 |
| Blockade of CTLA-4 and PD-1 enhances adoptive T-cell therapy efficacy in an ICOS-mediated manner LZ Shi, S Goswami, T Fu, B Guan, J Chen, L Xiong, J Zhang, D Ng Tang, ... Cancer Immunology Research 7 (11), 1803-1812, 2019 | 47 | 2019 |
| Case report: enfortumab vedotin for metastatic urothelial carcinoma: a case series on the clinical and histopathologic spectrum of adverse cutaneous reactions from fatal … PV Viscuse, ML Marques-Piubelli, MM Heberton, ER Parra, AY Shah, ... Frontiers in Oncology 11, 621591, 2021 | 44 | 2021 |
| Immunotherapy of cancer A Sharma, M Campbell, C Yee, S Goswami, P Sharma Clinical Immunology, 1033-1048. e1, 2019 | 28 | 2019 |
